RhumbLine Advisers’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$271K Buy
275,688
+39,658
+17% +$39K ﹤0.01% 3054
2025
Q1
$340K Sell
236,030
-10,884
-4% -$15.7K ﹤0.01% 2819
2024
Q4
$543K Buy
246,914
+3,824
+2% +$8.41K ﹤0.01% 2635
2024
Q3
$401K Sell
243,090
-8,948
-4% -$14.8K ﹤0.01% 2855
2024
Q2
$560K Buy
252,038
+248,254
+6,561% +$551K ﹤0.01% 2593
2024
Q1
$10.1K Hold
3,784
﹤0.01% 3871
2023
Q4
$11.3K Hold
3,784
﹤0.01% 3846
2023
Q3
$3.71K Sell
3,784
-3,353
-47% -$3.29K ﹤0.01% 4031
2023
Q2
$9.92K Sell
7,137
-92,514
-93% -$129K ﹤0.01% 3956
2023
Q1
$158K Buy
99,651
+6,823
+7% +$10.8K ﹤0.01% 2787
2022
Q4
$578K Buy
92,828
+7,216
+8% +$44.9K ﹤0.01% 2398
2022
Q3
$574K Buy
85,612
+9,899
+13% +$66.4K ﹤0.01% 2427
2022
Q2
$482K Buy
75,713
+21,996
+41% +$140K ﹤0.01% 2519
2022
Q1
$249K Buy
53,717
+22,584
+73% +$105K ﹤0.01% 2700
2021
Q4
$156K Sell
31,133
-479
-2% -$2.4K ﹤0.01% 2884
2021
Q3
$381K Sell
31,612
-1,266
-4% -$15.3K ﹤0.01% 2673
2021
Q2
$695K Buy
32,878
+807
+3% +$17.1K ﹤0.01% 2416
2021
Q1
$900K Sell
32,071
-2,876
-8% -$80.7K ﹤0.01% 2228
2020
Q4
$909K Buy
34,947
+948
+3% +$24.7K ﹤0.01% 2174
2020
Q3
$1.26M Sell
33,999
-9,610
-22% -$357K ﹤0.01% 1902
2020
Q2
$2.24M Buy
43,609
+5,462
+14% +$280K ﹤0.01% 1668
2020
Q1
$1.2M Sell
38,147
-804
-2% -$25.4K ﹤0.01% 1797
2019
Q4
$2.32M Buy
38,951
+2,834
+8% +$169K ﹤0.01% 1716
2019
Q3
$1.32M Buy
36,117
+210
+0.6% +$7.7K ﹤0.01% 1913
2019
Q2
$1.67M Buy
35,907
+4,680
+15% +$218K ﹤0.01% 1843
2019
Q1
$1.25M Sell
31,227
-356
-1% -$14.3K ﹤0.01% 1931
2018
Q4
$1.45M Buy
31,583
+9,836
+45% +$453K ﹤0.01% 1830
2018
Q3
$965K Sell
21,747
-1,314
-6% -$58.3K ﹤0.01% 2019
2018
Q2
$904K Buy
23,061
+5,867
+34% +$230K ﹤0.01% 2046
2018
Q1
$1.24M Sell
17,194
-740
-4% -$53.5K ﹤0.01% 1838
2017
Q4
$1.18M Sell
17,934
-2,566
-13% -$169K ﹤0.01% 1871
2017
Q3
$1.03M Buy
20,500
+1,960
+11% +$98.2K ﹤0.01% 1958
2017
Q2
$858K Sell
18,540
-640
-3% -$29.6K ﹤0.01% 2023
2017
Q1
$677K Buy
19,180
+2,846
+17% +$100K ﹤0.01% 2124
2016
Q4
$205K Sell
16,334
-1,002
-6% -$12.6K ﹤0.01% 2661
2016
Q3
$240K Buy
17,336
+150
+0.9% +$2.08K ﹤0.01% 2589
2016
Q2
$170K Buy
17,186
+3,657
+27% +$36.2K ﹤0.01% 2808
2016
Q1
$229K Buy
13,529
+80
+0.6% +$1.35K ﹤0.01% 2670
2015
Q4
$299K Buy
13,449
+1,375
+11% +$30.6K ﹤0.01% 2580
2015
Q3
$285K Buy
12,074
+589
+5% +$13.9K ﹤0.01% 2579
2015
Q2
$939K Buy
11,485
+6,195
+117% +$506K ﹤0.01% 1904
2015
Q1
$490K Buy
+5,290
New +$490K ﹤0.01% 2314